ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $315,380 | -7.1% | 3,368 | -11.4% | 0.19% | -4.5% |
Q2 2023 | $339,329 | +24.8% | 3,802 | +49.9% | 0.20% | +34.0% |
Q1 2023 | $271,910 | -10.6% | 2,536 | +1.8% | 0.15% | -5.7% |
Q4 2022 | $304,226 | +1.7% | 2,491 | -14.1% | 0.16% | +33.6% |
Q3 2022 | $299,000 | +12.8% | 2,900 | +1.5% | 0.12% | +21.4% |
Q2 2022 | $265,000 | -16.9% | 2,856 | +4.9% | 0.10% | -31.5% |
Q1 2022 | $319,000 | -12.8% | 2,722 | 0.0% | 0.14% | +3.6% |
Q4 2021 | $366,000 | +45.2% | 2,722 | +72.2% | 0.14% | +24.3% |
Q3 2021 | $252,000 | +15.1% | 1,581 | -5.0% | 0.11% | +23.3% |
Q2 2021 | $219,000 | +3.8% | 1,664 | +1.4% | 0.09% | +1.1% |
Q1 2021 | $211,000 | -21.6% | 1,641 | +1.7% | 0.09% | -20.5% |
Q4 2020 | $269,000 | -21.3% | 1,614 | -27.1% | 0.11% | -37.4% |
Q3 2020 | $342,000 | -7.8% | 2,215 | -11.8% | 0.18% | +1.7% |
Q2 2020 | $371,000 | +5.7% | 2,511 | -19.4% | 0.18% | +22.2% |
Q1 2020 | $351,000 | -29.4% | 3,117 | -12.7% | 0.14% | +77.8% |
Q4 2019 | $497,000 | +146.0% | 3,569 | +70.1% | 0.08% | +97.6% |
Q3 2019 | $202,000 | -20.8% | 2,098 | -5.2% | 0.04% | -24.1% |
Q2 2019 | $255,000 | -49.0% | 2,214 | -47.9% | 0.05% | -94.9% |
Q1 2019 | $500,000 | +66.7% | 4,250 | -11.3% | 1.06% | +1986.3% |
Q4 2018 | $300,000 | – | 4,789 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |